Skip to main content
Fig. 2 | BMC Pharmacology and Toxicology

Fig. 2

From: Cardioprotective effect of crude polysaccharide fermented by Trametes Sanguinea Lyoyd on doxorubicin-induced myocardial injury mice

Fig. 2

TSLFACP alleviates myocardial injury induced by DOX in vitro. A The effects of TSLFACP in different concentrations on the proliferation of H9C2 cells. B The effect of TSLFACP on the DOX-induced injury in the cardiomyocytes H9C2 cells. C The effect of TSLFACP on the DOX-induced injury in embryonic myocardial cell line CCC-HEH-2. D The morphology of H9C2 cells treated by DOX and TSLFACP (100 ×). The data is expressed as the x ± s (n = 4). *P < 0.05, ***P < 0.001 vs control; ##P < 0.01, ###P < 0.001 vs DOX

Back to article page